CSN Murthy

Chief Executive Officer

Mr. CSN Murthy began his career with ICICI Ventures, India’s first Venture Capital fund. He was subsequently a management consultant to the Pharma and Chemical sectors. Later, he worked in the Business Development and General Management functions in Pharmaceutical companies, including as the Chief Operating Officer of Gland Pharma Ltd. CSN holds a Bachelors degree in Chemical Engineering from the Indian Institute of Technology (IIT), Madras and an MBA from the Indian Institute of Management (IIM), Bangalore.


Murali Ramachandra

Chief Scientific Officer

Dr. Murali Ramachandra received his PhD from University of Idaho, USA and was a Postdoctoral fellow at DuPont Experimental Station and University of Kansas Medical Centre, Kansas City, USA. He has worked on various aspects of drug discovery at the National Institute of Health, USA and Schering-Plough, USA before joining Aurigene. He has co-authored more than 50 publications in peer-reviewed journals and is an inventor of 10 granted US patents.


Chetan Pandit

Senior Vice President
Medicinal Chemistry

Dr. Chetan Pandit completed his BSc from St.Stephen’s College, Delhi and received his PhD from State University of New York, Buffalo. He has over 20 years of Medicinal Chemistry and Process research experience in the Industry, in India and Canada. He currently holds 10 patents, including one for a compound currently in Phase I/II clinical trials.

Susanta Samajdar

Vice President
Medicinal Chemistry

Dr. Susanta Samajdar received his PhD in Synthetic Organic Chemistry from Indian Association for the Cultivation of Science (IACS), Kolkata and subsequently moved to MD Anderson Cancer Center for a Post-Doctoral training on anti-cancer drug discovery. He has over 10 years of synthetic and Medicinal Chemistry research experience in Indian Industries. Susanta has experience in leading multi-disciplinary drug discovery teams that successfully delivered several preclinical development candidates. He has experience in working with various target classes including GPCRs, Ion channels, Proteases, Kinases and NHRs, across different therapeutic areas like Oncology, Pain and Inflammation, Metabolic Disorders and Neurosciences. He has more than 20 publications and patents to his credit.


Shekar Chelur

Research Director
Preclinical Biology

Dr. Shekar Chelur is a board certified Toxicologist and Toxicologic Pathologist with over 15 years of research experience. He completed his graduate and post graduate studies in Veterinary Pathology from Bangalore Veterinary College. He has worked at Jai Research Foundation, Torrent Research Centre and Zydus Research Centre prior to joining Aurigene in 2004. He has experience in safety evaluation of NCE’s in the area of Metabolic Disorders, Cardiovascular diseases, Oncology, Pain, Inflammatory disorders, Immunomodulators and Musculoskeletal disorders. He is recipient of several merit scholarships including senior research fellowship from Indian Council of Agricultural Research. He is co-inventor of 3 international patents and author of 10 publications.

Thomas Antony

Research Director
In-Vitro Biology

Dr. Thomas Antony received his PhD from University of Delhi and was a Postdoctoral fellow at University of Medicine and Dentistry of New Jersey, USA, and Max Planck Institute for Biophysical Chemistry, Goettingen, Germany. He is a recipient of many research fellowships including UGC Junior and Senior Research Fellowships, Max Planck Fellowship and Alexander Von Humboldt Fellowship. Thomas has extensive drug discovery research experience in the areas of oncology, inflammation, metabolic disorders, and anti-infectives. He has co-authored more than 20 publications in peer-reviewed journals and is co-inventor of 3 international patents.

Ashish Lath

Vice President

Mr. Ashish Lath is a Chartered Accountant (CA). He has over 15 years of extensive experience across various finance, business planning and development functions. His earlier experience includes Deloitte & Mahindra and Mahindra. Prior to joining Aurigene, Ashish worked as CFO of Mahindra Reva Electric Vehicles.